Novartis Pakistan competitors and similar companiesClear all

Novartis Pakistan's competitors and similar companies include Laboratorios VALMOR, Lepu Biopharma, Andromaco and Teva Pharmaceuticals.

	Novartis Pakistan Novartis Pakistan is a pharmaceutical company that researches, develops, manufactures, and markets healthcare products.	Laboratorios VALMOR Laboratorios VALMOR is a manufacturer of pharmaceuticals.	Lepu Biopharma Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics.	Andromaco Andromaco is a pharmaceutical company.	Teva Pharmaceuticals Teva Pharmaceuticals is a global pharmaceutical company.
Founding Date	Founding Date 1996	Founding Date 1959	Founding Date 2018	Founding Date N/A	Founding Date 1901
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy
Locations	Locations Karachi, PK HQ	Locations Ejido, VE HQ	Locations HK HQ	Locations CL HQ	Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more
Employees	Employees 1222% decrease	Employees 1311% increase	Employees 3967% increase	Employees 1603% decrease	Employees 34,0048% decrease
Twitter followers	Twitter followers N/A	Twitter followers 580	Twitter followers N/A	Twitter followers N/A	Twitter followers 3.6 k
Employee Rating	Employee Rating N/A	Employee Rating 5	Employee Rating N/A	Employee Rating N/A	Employee Rating 3.6
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥15.6m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $14.9b (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥2m (FY, 2022)	Cost of goods N/A	Cost of goods $6.6b (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ¥24.7m (FY, 2022)	Gross profit N/A	Gross profit $8.4b (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income (¥699.4m) (FY, 2022)	Net income N/A	Net income ($2.4b) (FY, 2022)